Search

Search Constraints

You searched for: Author/Creator Nishio, Wataru

Search Results

1. Adjuvant atezolizumab in Japanese patients with resected stage IB‐IIIA non‐small cell lung cancer (IMpower010). Issue 12 (21st September 2022)

3. DLL3 expression is a predictive marker of sensitivity to adjuvant chemotherapy for pulmonary LCNEC. Issue 9 (21st July 2020)

8. Pleural invasion, epidermal growth factor receptor mutation and carcinoembryonic antigen level affect pleural lavage cytology-positive status in non-small-cell lung cancer. (16th November 2020)